Record Attendance in 2015
For the fourth year in a row, a record number of delegates participated in PEGS Europe! 700 attendees from more than 30 countries participated this year with even more expected in 2016. 46% of attendees were Scientists and another 27%
were Executives or Directors. 21% of attendees were from Big Pharma, 49% from biotech, and 22% from academia.
Testimonials from 2015
“Best biologics engineering and technology conference: a must-attend conference for novel biologics.”
- Rakesh D., Ph.D., VP, R&D, MedImmune
“PEGS Europe and PEGS keep going from strength to strength. One week at a PEGS event can stimulate ideas for a whole year.”
- Kevin R., Ph.D., Scientist, Wellcome Trust Sanger Institute
“Once more, PEGS Europe was an outstanding event with great science and a perfect setting for networking. Very nice combination of topics and speakers.”
- Philipp M., Ph.D., Project Leader, Biomedicine, University Hospital of Basel
“PEGS Europe is a gem for protein engineers with depth and breadth in a stimulating and engaging environment! I am glad that I came all the way from California to be a part of it!”
- Seung C., Ph.D., Associate Director, Cell Biology, Xencor, Inc.
Read More Testimonials
2015 Plenary Keynotes
![Lorenz Mayr Lorenz Mayr](mayr_lorenz.html)
Streamlining Protein Expression & Production
Lorenz Mayr, Ph.D., AstraZeneca
![Paul W.H.I. Parren Paul W.H.I. Parren](parren_paul.html)
Current and Future Trends in Antibody
Therapeutics
Paul W.H.I. Parren, Ph.D., Genmab B.V.
![Andreas Plückthun Andreas Plückthun](plueckthun_andreas.html)
Protein Engineering for New Modes
of Actions & New Targets
Andreas Plückthun, Ph.D., University of Zurich
![Tristan J. Vaughan Tristan J. Vaughan](vaughan_tristan.html)
Targeting Ion Channels
Tristan J. Vaughan, Ph.D., MedImmune Ltd.
![Gregory A. Weiss Gregory A. Weiss](weiss_gregory.html)
Mechanically Refolding Proteins beyond
Unboiling an Egg
Gregory A. Weiss, Ph.D., University of California, Irvine